Australia's Neurotech International slips most since April on discounted placement
** Neurotech International NTI.AX slips as much as 18.9% to A$0.015; marks biggest intraday pct decline since April 4 ** Stock hits lowest since September 22 ** Biopharmaceutical co announces A$4 million ($2.7 million) placement at A$0.014/share ** Issue price represents 26.3% discount to last close ** Funds raised will be applied towards registration-enabling clinical programmes, others ** Nearly 2 million shares traded, 4.1x the 30-day average ** YTD, NTI down 72.7% ($1 = A$1.5097) (Reporting by Roshan Thomas in Bengaluru) ((Roshan.Thomas@thomsonreuters.com;))
Recent news on Neurotech International
See all newsAustralia's Neurotech International slips most since April on discounted placement
Brief: Neurotech International Receives A$4 Million Placement Commitments
Brief: Neurotech International Requests Trading Halt Pending Capital Raising Announcement
Brief: Neurotech International Gets US FDA Rare Pediatric Disease Designation For NTI164
Australia's Neurotech International jumps as US FDA grants rare disease status for drug candidate